| Title: | Glucosamine Use, Inflammation, and Genetic Susceptibility, and Incidence of Type 2 Diabetes: A Prospective Study in UK Biobank |
| Journal: | Diabetes Care |
| Published: | 27 Jan 2020 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/31988063/ |
| DOI: | https://doi.org/10.2337/dc19-1836 |
| URL: | https://care.diabetesjournals.org/content/diacare/43/4/719.full.pdf |
| Citations: | 54 (29 in last 2 years) as of 8 Aug 2024 |
Publication 5087
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
OBJECTIVE: Glucosamine is a widely used supplement typically taken for osteoarthritis and joint pain. Emerging evidence suggests potential links of glucosamine with glucose metabolism, inflammation, and cardiometabolic risk. We prospectively analyzed the association of habitual glucosamine use with risk of type 2 diabetes (T2D) and assessed whether genetic susceptibility and inflammation status might modify the association.</p>
RESEARCH DESIGN AND METHODS: This study analyzed 404,508 participants from the UK Biobank who were free of diabetes, cancer, or cardiovascular disease at baseline and completed the questionnaire on supplement use. Cox proportional hazards models were used to evaluate the association between habitual use of glucosamine and risk of incident T2D.</p>
RESULTS: During a median of 8.1 years of follow-up, 7,228 incident cases of T2D were documented. Glucosamine use was associated with a significantly lower risk of T2D (hazard ratio 0.83, 95% CI 0.78-0.89) after adjustment for age, sex, BMI, race, center, Townsend deprivation index, lifestyle factors, history of disease, and other supplement use. This inverse association was more pronounced in participants with a higher blood level of baseline C-reactive protein than in those with a lower level of this inflammation marker (P-interaction = 0.02). A genetic risk score for T2D did not modify this association (P-interaction = 0.99).</p>
CONCLUSIONS: Our findings indicate that glucosamine use is associated with a lower risk of incident T2D.</p>
8 Authors
- Hao Ma
- Xiang Li
- Tao Zhou
- Dianjianyi Sun
- Zhaoxia Liang
- Ying Li
- Yoriko Heianza
- Lu Qi
Enabling scientific discoveries that improve human health